Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ganderton
Carl Ganderton, Rugeley GB
| Patent application number | Description | Published |
|---|---|---|
| 20100066358 | MAGNETIC SIGNATURE ASSESSMENT - Magnetic signature assessment apparatus for a vehicle comprising sensors for incorporation in the vehicle to measure the magnetic field normal to a closed surface at least approximately bounding the vessel and processing means for calculating from the normal field measurements a scalar magnetic potential outside the surface. Apparatus may be provided on the vehicle to generate a magnetic field to suppress the magnetic signature corresponding to the scalar potential. The invention also extends to corresponding methods and to programs for implementing those methods. | 03-18-2010 |
David Ganderton, Parma IT
| Patent application number | Description | Published |
|---|---|---|
| 20080247965 | PRESSURISED METERED DOSE INHALERS (MDI) - The invention relates to pressurized metered dose inhalers (MDIs) in which all or part of the internal surface is lined with an inert organic coating and which contain a formulation which comprises TA 2005. | 10-09-2008 |
| 20090263488 | PRESSURISED METERED DOSE INHALERS CONTAINING SOLUTIONS OF BETA-2 AGONISTS - The present invention relates to a pharmaceutical formulation for use in the administration of 2(1H)-quinolinone derivatives long-acting β | 10-22-2009 |
| 20110061651 | FORMOTEROL SUPERFINE FORMULATION - A metal container and a method of preparing a metal container for a pharmaceutical formulation where the active ingredient is formoterol, a stereoisomer of formoterol, and a physiologically acceptable salt of formoterol, in a solution of a liquefied HFA propellant. | 03-17-2011 |
| 20110100361 | PRESSURISED METERED DOSE INHALERS (MDI) - The invention relates to pressurized metered dose inhalers (MDIs) in which all or part of the internal surface is lined with an inert organic coating and which contain a formulation which comprises TA 2005. | 05-05-2011 |
David Ganderton, Bishop GB
| Patent application number | Description | Published |
|---|---|---|
| 20100018523 | Composition, device, and method for treating sexual dysfunction via inhalation - A composition, device, and method for treating sexual dysfunction via inhalation is provided which comprises inhaling a dose of a powder composition, the powder composition comprising apomorphine or pharmaceutically acceptable salts thereof. Preferably, the powder composition further includes a carrier material, the carrier material has an average particle size of from about 40 to about 70 microns, and at least 90 percent of said apomorphine has a particle size of 5 microns or less. | 01-28-2010 |
| 20100297030 | Composition, device, and method for treating sexual dysfunction via inhalation - A composition, device, and method for treating sexual dysfunction via inhalation is provided which comprises inhaling a dose of apomorphine or pharmaceutically acceptable salt(s) or ester(s) thereof. | 11-25-2010 |
David Ganderton, Wiltshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20100288276 | COMPOSITIONS FOR TREATING PARKINSON'S DISEASE - The present invention relates to improved treatment of diseases and disorders of the central nervous system by administration of apomorphine. In particular, the administration is via pulmonary inhalation. The invention provides the means for improving the treatment of a number of conditions, including Parkinson's Disease. | 11-18-2010 |
David Ganderton, Chippenham GB
| Patent application number | Description | Published |
|---|---|---|
| 20110217339 | MUCOACTIVE AGENTS FOR TREATING A PULMONARY DISEASE - The present invention relates to pharmaceutical compositions which are useful in the treatment of diseases where excess mucus is present in the respiratory tract, such as cystic fibrosis and chronic obstructive pulmonary disease. In particular, the invention relates to pharmaceutical compositions for administration by pulmonary inhalation. | 09-08-2011 |
Davis Ganderton, Parma IT
| Patent application number | Description | Published |
|---|---|---|
| 20090311196 | PHARMACEUTICAL AEROSOL COMPOSITION - Compositions which contain an active ingredient, a propellant containing a hydrofluoroalkane (HFA), a co-solvent, and a low-volatility component are useful for administering the active ingredient via an aerosol. | 12-17-2009 |